Neurovalens is a medical device that helps provide non-invasive electrical stimulations to a small electrical pulse to treat insomnia and anxiety. A U.S. medical regulator made this device a Belfast-based startup that later became the medical device for head-mounted treatment. With technological advancement, this medical device delivers non-invasive therapies to the human nervous system and improves sleep disorders.
Two neurovalens medical devices have been successfully approved. These devices help to treat insomnia and anxiety. Also, many other devices are becoming ready to treat other disorders like obesity and depression. These devices are hoping to provide other services regarding health care.
According to the Neurovalens announcement, they funded around $2.1 million with the investors and raised around $11 million equity for funding from the U.K. investors. They also work on various global technologies and neurosciences to treat other health issues. This health tech startup adopts a unique approach to treating specific health conditions.
According to the FDA, the 510K pathway will approve treating the GAD as a stress modius device in the U.S. and following the past sleep modius device that helps treat insomnia. Many other methods for neurostimulation target the brain areas and provide more accurate stimulation.
Read Also: What Is 2 2 2 Method Metabolism? A Complete Guide About It
As neurovalens use methods to regulate the paths and stimulate with more non-invasive cranial nerves, they have access to success worldwide. The latest devices, like Modius Stress, which the FDA approves, provide wellness to all individuals, working to provide security and health and to prevent many brain and nervous system disorders. Neurovalens started introducing innovative solutions by delivering trials and regulatory clearance. They are not just working and caring for mental health and well-being. They are also trying to invest in more advanced therapies and treatments regarding non-invasive neurostimulation.
